dynam
signific
aerosol
transmiss
respiratori
virus
still
controversi
major
reason
viru
aerosol
ineffici
collect
commonli
use
air
sampler
collect
virus
inactiv
collect
method
without
knowledg
viru
viabil
infect
risk
analys
lack
accuraci
pilot
studi
perform
determin
whether
infecti
viabl
respiratori
virus
aerosol
could
collect
air
real
world
environ
viabl
viru
aerosol
sampler
viva
ii
compar
contrast
efficaci
standard
bioaerosol
sampler
biosampl
viva
collect
airborn
virus
real
world
environ
iii
gain
insight
use
viva
respiratori
viru
sampl
viva
oper
via
water
vapor
condens
process
enlarg
aerosol
viru
particl
facilit
captur
varieti
viabl
human
respiratori
virus
includ
influenza
virus
influenza
b
virus
collect
viva
locat
least
seat
patient
lateonset
influenza
viru
outbreak
wherea
biosampl
oper
follow
optim
paramet
also
collect
viru
aerosol
nevertheless
overal
less
success
base
lower
frequenc
viru
isol
case
sidebysid
comparison
highlight
limit
past
studi
base
impingementbas
sampl
may
gener
falseneg
result
due
either
poor
collect
effici
andor
viru
inactiv
due
collect
process
import
signific
viru
aerosol
natur
transmiss
respiratori
diseas
contenti
issu
primarili
difficult
collect
sampl
viru
aerosol
use
current
avail
air
sampl
devic
test
new
air
sampler
base
water
vapor
condens
effici
sampl
viabl
airborn
respiratori
virus
student
health
care
center
model
real
world
environ
new
sampler
outperform
industri
standard
devic
skc
biosampl
collect
natur
viru
aerosol
maintain
viru
viabil
result
use
viva
indic
respiratori
viru
aerosol
preval
potenti
pose
greater
inhal
biohazard
previous
thought
viva
thu
appear
use
apparatu
microbiolog
air
qualiti
test
relat
detect
viabl
airborn
virus
irborn
infecti
agent
health
care
facil
pose
risk
patient
employe
nosocomi
transmiss
human
influenza
viru
respiratori
virus
major
concern
health
care
facil
especi
immunocompromis
patient
may
present
set
greater
risk
get
infect
vulner
develop
sever
diseas
transmiss
influenza
virus
one
person
anoth
occur
three
rout
direct
contact
infecti
secret
mucu
membran
upper
respiratori
tract
urt
contact
viruscontain
larg
droplet
spray
surfac
urt
inhal
small
aerosol
droplet
nuclei
deposit
lower
respiratori
tract
lrt
fourth
rout
shown
anim
model
ocular
infect
wherein
airborn
influenza
virus
come
contact
ocular
surfac
rel
import
transmiss
rout
poorli
understood
probabl
vari
depend
viru
strain
environment
condit
etc
among
aerosol
transmiss
mode
contenti
one
regard
econom
reason
expens
precaut
would
need
implement
appropri
infect
control
process
health
care
set
ii
fact
clear
evid
exist
one
extrapol
result
lab
experi
real
life
anim
human
be
artifici
aerosol
produc
lab
quit
differ
natur
aerosol
gener
cough
sneez
activ
unfortun
infect
control
perspect
peopl
get
infect
via
aerosol
transmiss
addit
intervent
use
respir
rather
surgic
mask
increas
air
ventil
isol
infect
patient
use
filtrat
system
use
larg
droplet
would
advis
would
increas
health
care
cost
therefor
new
sampl
method
need
better
understand
import
natur
aerosol
transmiss
rout
influenza
viru
respiratori
virus
util
infect
control
best
practic
reduc
nosocomi
transmiss
aerosol
virus
lindsley
et
al
studi
gener
infecti
influenza
viru
infect
patient
cough
exhal
use
skc
biosampl
assess
possibl
transmiss
mode
found
cough
breath
import
activ
airborn
influenza
viru
transmiss
suggest
mani
viabl
influenza
viruscontain
particl
might
origin
deep
lung
lednicki
loeb
isol
viabl
influenza
viru
skc
biosampl
person
cascad
impactor
sampler
pci
locat
sick
subject
milton
et
al
found
fine
particl
ie
aerosol
transmiss
mode
contain
viru
genom
equival
coars
particl
ie
droplet
transmiss
mode
surgic
mask
effect
fine
particl
coars
particl
howev
studi
hinder
limit
air
sampl
detect
method
avail
airborn
virus
sampler
commonli
use
viru
sampl
cascad
impactor
biosampl
base
inerti
impact
thu
design
collect
larger
particl
nm
fungal
spore
bacteria
design
ineffici
collect
nanoparticl
exampl
commonli
use
skc
biosampl
shown
less
physic
collect
effici
aerosol
bacteriophag
nm
signific
proport
virus
becom
inactiv
sampl
process
biosampl
less
collect
effici
laboratorygener
aerosol
infecti
influenza
viru
although
filter
like
teflon
filter
gelatin
filter
high
collect
effici
wide
size
rang
particl
nanomet
micromet
influenza
virus
tend
becom
inactiv
collect
filter
pcr
method
wide
use
viru
quantif
provid
total
count
viral
genom
genom
equival
discrimin
genom
correspond
viabl
versu
nonviabl
virus
difficulti
might
account
result
studi
report
lindsley
et
al
wherein
influenza
viru
rna
detect
test
subject
yet
infecti
viru
isol
subject
therefor
hard
know
whether
low
infecti
viru
recoveri
report
literatur
meaning
due
poor
collect
methodolog
airborn
virus
andor
inactiv
virus
sampl
process
studi
evalu
efficaci
viva
collect
airborn
influenza
viru
respiratori
virus
student
health
care
center
cours
lateonset
influenza
viru
outbreak
ongo
studi
focus
collect
airborn
influenza
virus
subsequ
carri
influenza
viru
genom
sequenc
analys
gain
insight
strain
collect
univers
florida
uf
highli
vaccin
cohort
student
staff
viru
genom
sequenc
inform
use
vaccin
efficaci
infect
control
purpos
viru
surveil
effort
viva
use
waterbas
condens
growth
system
enabl
collect
aerosol
particl
nm
importantli
enlarg
respir
particl
waterbas
condens
occur
natur
breath
previous
use
viva
success
collect
laboratorygener
influenza
viru
aerosol
wherein
collect
effici
viabl
influenza
viru
high
collect
effici
attribut
inher
gentler
impact
viva
viru
collect
medium
preserv
infect
well
high
physic
collect
effici
particl
wide
size
rang
viva
tool
investig
whether
infecti
respiratori
viru
aerosol
could
collect
air
student
infirmari
influenza
outbreak
model
potenti
use
real
world
environ
isol
identif
viabl
virus
aerosol
collect
march
viabl
human
respiratori
virus
recov
viva
biosampl
three
separ
air
sampl
interv
perform
march
virus
recov
control
run
perform
hepafilt
viva
biosampl
air
intak
cytopath
effect
cpe
consist
caus
influenza
virus
observ
mdck
cell
begin
day
postinocul
pi
suggest
possibl
influenza
b
viru
isol
see
fig
supplement
materi
moreov
syncytia
consist
expect
human
respiratori
syncyti
viru
rsv
also
observ
vero
cell
regardless
trypsin
content
effect
much
pronounc
easiest
detect
cell
serumfre
cell
growth
medium
ad
tosylsulfonyl
phenylalanyl
chloromethyl
keton
tpck
trypsin
syncytia
becam
evid
begin
day
postinocul
cell
trypsin
day
later
trypsinfre
cell
contrast
cpe
observ
mockinocul
cell
control
run
hepafilt
sampler
though
onset
vari
accord
sampl
interv
case
cpe
observ
first
cell
inocul
collect
media
viva
solidphas
enzymelink
immunosorb
assay
elisa
result
indic
influenza
b
virus
isol
viva
sampl
fig
remark
revers
trancriptionpcr
rtpcr
indic
influenza
viru
subtyp
isol
well
victorialineag
influenza
b
viru
similarli
rsva
identifi
cell
cultur
virus
detect
per
sampl
interv
list
tabl
genbank
access
number
influenza
viru
sequenc
list
tabl
rsva
summar
tabl
sequenc
data
analys
reveal
virus
belong
ha
subclad
base
criteria
mention
refer
result
present
text
tabl
refer
strain
recent
local
virus
isol
human
air
sampl
studi
similar
analys
perform
outlin
refer
indic
influenza
virus
belong
ha
clade
subclad
virus
amino
acid
chang
major
immunogen
epitop
hemagglutinin
ha
protein
tabl
neuraminidas
na
protein
tabl
rel
vaccin
strain
final
influenza
viru
b
strain
victoria
lineag
clade
virus
discuss
refer
rsva
sequenc
alik
four
isol
ident
report
contemporari
rsva
virus
circul
unit
state
data
shown
fig
exampl
cell
cultur
depict
virusinduc
cpe
given
fig
sequenc
influenza
virus
reveal
clade
clade
victorialineag
influenza
b
virus
isol
march
air
sampl
rsva
sequenc
ident
rsva
sequenc
march
project
origin
design
answer
whether
influenza
viru
aerosol
could
detect
student
health
care
center
virus
sequenc
identifi
base
combin
diagnost
pcr
rtpcr
genmark
analys
isol
one
type
viru
aerosol
april
unlik
result
first
two
air
sampl
studi
neither
influenza
virus
rsva
isol
final
air
sampl
studi
student
health
care
center
result
line
observ
among
air
sampl
date
fewest
number
patient
count
wait
room
april
cell
cultur
posit
viru
isol
human
metapneumoviru
subtyp
moreov
viru
isol
one
sampl
collect
use
viva
inocul
onto
cell
serumfre
medium
trypsin
requir
incub
cpe
form
infect
cell
data
shown
evalu
viru
aerosol
collect
capabl
novel
air
sampler
viva
standard
air
sampler
biosampl
student
infirmari
center
lateonset
influenza
outbreak
span
midfebruari
earli
april
experi
perform
three
time
day
three
separ
day
first
experi
march
infecti
influenza
virus
influenza
b
virus
rsv
present
collect
medium
viva
air
sampl
interv
biosampl
sampl
tabl
second
experi
march
influenza
b
virus
rsv
collect
air
sampler
air
sampl
interv
tabl
though
note
influenza
virusspecif
cpe
detect
earlier
mdck
cell
inocul
viva
collect
medium
influenza
viru
rsv
collect
third
experi
april
human
respiratori
virus
also
collect
second
experi
tabl
wherea
human
metapneumoviru
detect
one
sampl
collect
use
viva
third
experi
previou
studi
viva
similar
devic
compar
biosampl
collect
laboratorygener
viruscontain
particl
nm
larger
studi
viva
outperform
biosampl
collect
influenza
viru
bacteriophag
aerosol
due
gentl
impact
size
amplif
result
studi
also
indic
viva
better
biosampl
collect
viru
aerosol
preserv
viru
viabil
real
world
environ
possibl
reason
includ
follow
gentler
impact
viva
less
damag
virus
collect
process
ii
viva
higher
physic
collect
effici
biosampl
particl
small
nm
due
amplif
result
apart
choic
proper
sampl
locat
presenc
emit
sourc
favor
success
detect
agent
whose
transmiss
evalu
experi
locat
chosen
student
infirmari
agent
influenza
b
viru
emit
sourc
person
activ
respiratori
infect
breath
cough
talk
andor
sneez
find
consist
previous
mention
item
inform
regard
lateonset
influenza
season
provid
state
florida
depart
health
reinforc
notion
success
detect
viru
aerosol
favor
locat
select
ie
viru
aerosol
highest
enclos
site
numer
sick
person
time
test
ie
likelihood
find
viru
aerosol
higher
outbreak
respiratori
infect
anoth
three
set
air
sampl
perform
use
biosampl
viva
three
differ
day
influenza
outbreak
august
septemb
small
classroom
uf
black
hall
viabl
respiratori
virus
isol
data
shown
sampl
site
least
patient
result
support
notion
aerosol
transmiss
mode
possibl
influenza
virus
variou
studi
indic
temper
climat
influenza
outbreak
typic
occur
late
fall
earli
winter
cold
humid
low
lateonset
influenza
outbreak
florida
span
februari
begin
april
thu
like
influenza
virus
present
breath
air
infirmari
present
extrem
low
concentr
april
outbreak
declar
student
sought
medic
treatment
respiratori
infect
day
contrast
influenza
season
near
peak
level
march
influenza
virus
isol
air
sampl
march
viral
genom
sequenc
analys
indic
influenza
virus
pandem
year
lineag
howev
unlik
influenza
viru
ha
clade
use
northern
hemispher
influenza
viru
vaccin
virus
isol
work
ha
clade
text
signatur
amino
acid
substitut
defin
subgroup
virus
addit
variat
observ
includ
februari
virus
unioneuropean
econom
area
countri
addit
substitut
newer
strain
also
substitut
well
situat
north
america
similar
wherea
variou
viru
cluster
emerg
within
clade
two
domin
subclad
wide
circul
virus
subclad
amino
acid
substitut
result
format
new
potenti
glycosyl
motif
residu
subclad
virus
amino
acid
substitut
shown
tabl
chang
key
amino
acid
posit
ha
protein
virus
work
rel
vaccin
strain
chang
observ
strain
time
period
isol
human
data
shown
importantli
chang
also
occur
amino
acid
sequenc
na
protein
tabl
matrix
protein
tabl
similarli
seven
genet
group
base
ha
gene
defin
virus
sinc
contemporari
virus
belong
clade
three
subdivis
epitop
virus
studi
ha
subclad
tabl
also
amino
acid
chang
na
protein
tabl
final
influenza
b
virus
victoria
lineag
wherea
commonli
use
influenza
trival
vaccin
yamagatalineag
strain
given
uf
highli
vaccin
student
worker
popul
find
rais
question
whether
somemost
influenza
viru
vaccin
use
season
good
match
influenza
virus
circul
earli
florida
limit
pilot
studi
first
viva
biosampl
use
collect
viru
aerosol
particl
size
determin
wellknown
respiratori
virus
present
differents
airborn
particl
particular
influenza
viru
detect
cough
exhal
influenza
virus
found
particl
size
term
fine
particl
stay
airborn
much
longer
larger
particl
travel
much
longer
distanc
although
import
particl
viru
transmiss
remain
controversi
studi
viva
biosampl
locat
least
seat
patient
viabl
infecti
influenza
b
virus
isol
respiratori
virus
also
isol
suggest
patient
type
respiratori
virus
also
produc
small
aerosol
contain
infecti
virus
futur
studi
consid
particl
size
character
better
identif
possibl
effect
exposur
viru
particl
deposit
respiratori
track
second
two
locat
health
care
facil
test
studi
sampl
size
small
studi
sampl
locat
time
would
use
quantifi
abil
viva
sampl
differ
kind
infecti
virus
biosampl
studi
suggest
viva
perform
well
collect
viru
aerosol
preserv
viru
viabil
real
world
environ
addit
benefit
viru
aerosol
collect
onto
small
volum
collect
medium
simplifi
downstream
oper
includ
storag
transport
viru
isol
moreov
mani
type
airborn
virus
includ
influenza
b
virus
adenoviru
coronaviru
human
parainfluenza
viru
respiratori
syncyti
viru
success
collect
viva
indic
devic
potenti
use
gener
surveil
airborn
virus
procedur
review
approv
director
student
health
center
approv
institut
review
board
irb
necessari
human
subject
studi
could
identifi
sourc
virus
detect
could
track
health
care
facil
student
health
care
center
univers
florida
gainesvil
fl
freestand
build
heat
ventil
air
condit
hvac
system
studi
indoor
air
temperatur
maintain
around
first
floor
second
floor
wherea
rel
humid
rang
floor
air
sampl
small
classroom
anoth
uf
build
black
hall
conduct
comparison
black
hall
also
hvac
system
wherein
indoor
temperatur
typic
around
rel
humid
around
work
perform
sampl
date
air
sampl
student
health
care
center
perform
march
march
april
influenza
outbreak
gainesvil
march
air
sampl
black
hall
perform
august
august
septemb
aerosol
collect
system
ambient
viru
aerosol
particl
student
health
care
center
black
hall
collect
use
viva
skc
biosampl
collect
system
schemat
depict
fig
viva
collect
mechan
previous
describ
briefli
passag
cool
temperatur
condition
initi
activ
grow
particl
small
nm
droplet
greater
diamet
fig
enlarg
particl
subsequ
direct
set
nozzl
diamet
gentl
collect
onto
ml
collect
medium
consist
phosphatebuff
salin
pb
plu
wtvol
bovin
serum
albumin
bsa
fraction
v
petri
dish
biosampl
present
consid
refer
air
sampler
collect
airborn
bacteria
fungi
use
attempt
collect
viru
aerosol
use
intak
air
divert
three
tangenti
nozzl
collect
medium
result
swirl
airflow
airflow
reduc
impact
forc
particl
deposit
onto
collect
medium
collect
medium
use
biosampl
necess
volum
biosampl
ml
avoid
discrep
viru
concentr
due
sampl
locat
inlet
viva
biosampl
bound
togeth
viva
biosampl
oper
flow
rate
litersmin
sampl
rate
effect
air
sampler
collect
viru
aerosol
mainten
viru
infect
compar
standard
flow
rate
litersmin
reduc
nois
sampl
pump
welch
model
place
within
cover
box
air
sampler
placement
layout
studi
area
ceil
vent
air
sampler
posit
student
health
care
center
shown
fig
first
sampl
march
conduct
first
floor
lobbi
near
center
recept
desk
fig
air
sampl
observ
peopl
sat
near
receptionist
desk
mani
took
drink
fountain
second
third
air
sampl
march
april
air
sampler
posit
within
wait
room
second
floor
fig
may
wait
room
visibl
crowd
peopl
wait
medic
attent
mani
observ
cough
sneez
obviou
sign
respiratori
infect
contrast
rel
patient
present
april
air
sampl
classroom
black
hall
conduct
right
class
student
remain
room
inlet
air
sampler
set
height
orient
horizont
ground
face
peopl
approxim
averag
height
seat
adult
person
negativecontrol
run
also
perform
higheffici
particul
air
hepa
filter
instal
inlet
sampler
collect
time
min
use
sampl
liter
air
air
sampl
negativecontrol
run
conduct
altern
upon
complet
air
sampl
pump
shut
viva
biosampl
disconnect
collect
medium
apparatu
asept
transfer
steril
conic
polypropylen
tube
immedi
place
insul
box
ice
pack
transport
laboratori
similar
sampl
procedur
follow
sampl
black
hall
wherein
sampler
place
front
corner
classroom
close
podium
virolog
laboratori
virolog
work
perform
biosafeti
level
enhanc
laboratori
uf
air
sampler
collect
medium
volum
reduct
adjust
standard
volum
obviat
largescal
cell
cultur
viru
isol
attempt
air
sampler
collect
medium
sampl
concentr
use
amicon
centrifug
filter
unit
membran
molecular
mass
cutoff
kda
millipor
bedford
g
min
volum
approxim
l
volum
adjust
l
addit
collect
medium
concentr
store
viru
isol
cell
cultur
attempt
cell
line
emphasi
isol
influenza
virus
genet
analys
thereof
lesser
effort
nevertheless
exert
isol
common
cultur
human
respiratori
virus
gain
insight
gener
util
viva
viru
aerosol
term
cultur
refer
virus
isol
propag
use
standard
cell
line
method
favor
isol
wide
varieti
respiratori
virus
concentr
air
sampl
collect
media
inocul
onto
varieti
readili
avail
standard
cell
line
obtain
american
type
cultur
collect
atcc
viru
isol
attempt
includ
follow
hela
mdck
vero
common
human
respiratori
virus
isol
use
cell
shown
tabl
bonni
j
lednicki
unpublish
data
cell
line
propag
monolay
co
advanc
dulbecco
modifi
eagl
medium
admem
eagl
minim
essenti
medium
emem
invitrogen
carlsbad
ca
appropri
per
cell
line
prior
prepar
seed
stock
cell
line
treat
week
plasmocin
verifi
free
mycoplasma
dna
pcr
inocul
identif
human
respiratori
virus
thaw
ice
equal
aliquot
l
archiv
concentr
air
sampler
collect
media
inocul
directli
without
prefiltr
onto
newli
confluent
cell
plate
inocul
cell
incub
plate
monitor
daili
sign
virusinduc
cpe
ie
format
visibl
chang
appear
nuclei
infect
cell
togeth
format
focal
enlarg
granular
cell
nonspecif
cell
deterior
follow
detach
swollen
cell
growth
surfac
refe
perform
everi
day
noninfect
cell
maintain
refe
parallel
comparison
cell
maintain
observ
total
day
consid
neg
viru
isol
virus
identifi
base
cell
tropism
tabl
type
cpe
induc
use
genmark
respiratori
viru
panel
solidphas
elisa
influenza
b
virus
groupandor
viru
speciesspecif
pcr
rtpcr
sequenc
virusspecif
pcr
amplicon
complet
viru
genom
genmark
respiratori
viru
panel
genmarkdx
multiplex
pcr
esensor
respiratori
viral
panel
esensor
rvp
genmark
diagnost
inc
carlsbad
ca
use
screen
spent
cell
growth
media
genom
dna
rna
respiratori
virus
accord
manufactur
instruct
techniqu
detect
genom
materi
influenza
viru
includ
subtyp
influenza
viru
influenza
b
viru
respiratori
syncyti
virus
b
parainfluenza
virus
human
metapneumoviru
adenovirus
c
coronavirus
human
rhinovirus
b
commerci
solidphas
elisa
quickvu
influenza
b
kit
quidel
corp
san
diego
ca
use
per
manufactur
instruct
quickli
detect
influenza
viru
spent
media
cell
cultur
exhibit
typic
influenza
virusinduc
cpe
elisa
distinguish
influenza
viru
type
identif
influenza
viru
type
subtyp
genom
sequenc
detect
viru
use
quickvu
influenza
b
kit
genmark
system
viral
rna
purifi
viru
particl
spent
mdck
cell
growth
medium
preliminari
analys
perform
rtpcr
use
primer
list
tabl
establish
viru
type
subtyp
sequenc
influenza
viru
genom
segment
ha
gene
na
gene
gene
influenza
b
viru
segment
ha
gene
nb
glycoprotein
na
gene
gene
accomplish
follow
previous
describ
method
identif
rsva
rsv
subtyp
b
induc
format
syncytia
vero
cell
lesser
extent
cell
gener
rsvinduc
cpe
first
detect
cell
vero
cell
lastli
cell
regardless
presenc
absenc
trypsin
howev
syncytia
gener
observ
earlier
rsvinfect
cell
cultur
trypsin
present
sinc
mani
virus
induc
format
syncytia
confirm
addit
test
requir
syncytiumform
virus
identifi
rsva
analys
vrna
purifi
day
septemberoctob
volum
issu
msphereasmorg
postinfect
viru
particl
spent
cell
growth
medium
tpckcontain
cell
text
use
genmark
system
rtpcr
follow
sequenc
pcr
amplicon
identif
miscellan
respiratori
virus
adenoviru
c
type
human
parainfluenza
virus
human
coronavirus
human
metapneumoviru
identifi
use
genmark
system
use
publish
pcrbase
method
detail
avail
upon
request
supplement
materi
articl
may
found
http
text
docx
file
mb
